- Home
- Products
- Prescription: cardiometabolic
- Verapamil-Darnitsa
Verapamil-Darnitsa
Release forms:
- Film-coated tablets
- Solution for injection
Paroxysmal supraventricular tachycardia, atrial flutter/fibrillation (not including Wolff–Parkinson–White syndrome (WPW)).
Unstable angina in patients for whom nitrates and/or β˗blockers are contraindicated, including vasospastic angina, Prinzmetal's variant angina.
Arterial hypertension; hypertensive crisis.
In children: in paroxysmal supraventricular tachycardia.
Characteristics of the productу:
- Release formInjectable solution
- ChildrenWith caution
- PregnantWith caution
- NursingWith caution
- Release categoryPrescription medication
- With alcoholWith caution
- DriversWith caution
- Temperature storage conditionsNot higher than 25 °С
- Qualitative and quantitative composition:
- Pharmaceutical form.
- Clinical particulars.
- Children
- Overdose.
- Packaging.
- Category of release
- Manufacturer.
- The manufacturer's location and address of the place of business.
- Date of last revision.